Global Cardiac Biomarker Diagnostic Kits Market Size By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome), By Biomarker (Troponin, Bnp, Myoglobin), By End-Use (Hospital, Specialty Clinics), By Geographic Scope And Forecast

Cardiac Biomarker Diagnostic Kits Market Size And Forecast

Cardiac Biomarker Diagnostic Kits Market size was valued at USD 2.71 Billion in 2023 and is projected to reach USD 4.13 Billion by 2030, growing at a CAGR of 5.37% during the forecast period 2024-2030.

Some of the key contributing factors propelling the growth of the Global Cardiac Biomarker Diagnostic Kits Market are the increase in the prevalence of cardiovascular diseases and an inclination of the population towards the treatment of chronic and lifestyle diseases across the globe. The Global Cardiac Biomarker Diagnostic Kits Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Biomarker Diagnostic Kits Market Definition

Cardiac biomarkers such as enzymes, hormones, and proteins are released into the blood in conditions when the heart is stressed or damaged. Cardiac biomarkers are used to evaluate the heart function of patients with chest pain and suspected acute coronary syndrome. Cardiac Biomarker Diagnostic Kits play a critical role in the early detection or prediction of heart-related ailments.

In the triage and management of a range of cardiac-related conditions, cardiac biomarkers are crucial, where time delay has a significant impact on the short and longer-term outcomes of a patient. Conditions that can be diagnosed include myocardial infarction, heart attack, acute coronary syndrome, or ACS among others.

Global Cardiac Biomarker Diagnostic Kits Market Overview

There has been a growing prevalence of lifestyle diseases such as hypertension, obesity, and diabetes among others, which are major risk factors for cardiovascular diseases. The increasing instances of cardiovascular diseases are an important driver for the global market. Another major factor propelling the growth in the global Cardiac Biomarker Diagnostic Kits Market is the rising geriatric population coupled with growing public health awareness. Other important drivers are the inclination of the population towards the treatment of chronic and lifestyle diseases and improving healthcare infrastructure in developing economies.

The ongoing clinical trials for the identification of rapid and novel cardiac biomarkers coupled with growing investment from public and private organizations for research and development are expected to provide new profitable opportunities leading to the rapid growth of the market. Furthermore, technological advancements leading to early detection to track heart conditions and integration of cardiology & IT will also provide opportunities for the growth of the market.

Other opportunities lie in the adoption of point-of-care testing with cardiac biomarkers. Thus, there are ample growth opportunities for the market. However, there are some restraints like the requirement of careful handling and storage of precious biological samples and the higher time required to obtain results for some of the biomarker tests. These may adversely impact the growth of the Global Cardiac Biomarker Diagnostic Kits Market.

Global Cardiac Biomarker Diagnostic Kits Market Segmentation Analysis

The Global Cardiac Biomarker Diagnostic Kits Market is Segmented on the basis of Indication, Biomarker, End-Use, And Geography.

Cardiac Biomarker Diagnostic Kits Market, By Indication

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Others

Based on Indication, The market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others. the Acute Coronary Syndrome segment holds the highest market share owing to its rising prevalence followed by the Myocardial Infection segment.

Cardiac Biomarker Diagnostic Kits Market, By Biomarker

• Troponin
• Bnp
• Myoglobin
• Others

Based on Biomarker, The market is segmented into Troponin, Bnp, Myoglobin, and Others. the troponin segment is expected to grow at the fastest rate owing to higher adoption by the end-users. The rising prevalence of Acute Coronary Syndrome and Myocardial Infection will propel the demand for troponin tests.

Cardiac Biomarker Diagnostic Kits Market, By End-Use

• Hospital
• Specialty Clinics

Based on End-Use, The market is segmented into Hospital and Specialty Clinics. the hospital is the leading segment owing to higher healthcare expenditure and the development of new hospitals in developing countries. However, the specialty clinics segment is growing fast due to the increasing numbers of such clinics in developed countries and the availability of specialized and customized testing and treatment of the patients.

Cardiac Biomarker Diagnostic Kits Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Cardiac Biomarker Diagnostic Kits Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America leads the market share of the global market. This is owing to growing instances of cardiovascular and lifestyle diseases, and increasing investments into the healthcare infrastructure. The Asia Pacific is also growing fast due to the rapidly developing healthcare infrastructure along with the rise in the use of technologically advanced cardiac biomarkers.

Key Players

The “Global Cardiac Biomarker Diagnostic Kits Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Hoffmann-La Roche AG, Abbott Laboratories, Roche Diagnostics Limited, Danaher Corporation, Bio-Rad Laboratories, Siemens AG, Thermo Fisher Scientific, Ortho Clinical Diagnostics, and Randox Laboratories Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• May 2020 – Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer.
• April 2019 – US FDA has approved Ortho Clinical Diagnostics VITROS XT MicroSlides which features new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide.
• September 2018 – Abbott receives CE Mark for first troponin test to help predict the chance of heart attack in apparently healthy adults potentially months to years in advance.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.